Plymouth based Celcuity gets closer to having its advanced breast cancer drug approved.
- Posted on September 16, 2025
- By Star Tribune
- 1 Views
Plymouth based Celcuity gets closer to having its advanced breast cancer drug approved.
Phase III trial results help Celcuity's stock price to soar and allowed the company to raise almost $300 million to continue towards commercialization.
